NTRA

#445
Natera, Inc. Common Stock
211.49 USD
+4.75%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
210.43
211.87
Intervallo Annuale
131.81
256.27
Variazione giornaliera
+4.75%
Variazione Mensile
+10.47%
Variazione di 6 mesi
+22.08%
Variazione Annuale
+42.04%
Chiusura Precedente
201.90
Apertura
210.66
Bid
Ask
Minimo
210.43
High
211.87
Volume
80
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 29.97 B
  • Employee 6 140
  • Founded 2004
  • CEO Steven Chapman
  • Website www.natera.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BQ86
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-150.72
Rapporto prezzo/fatturato
13.58

Natera Inc

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

Notizie